在药物发现和开发中进行空间生物学研究的最佳实践框架:使用数字空间分析进行成功的队列研究
David Krull1, Premi Haynes2, Anil Kesarwani1
1Precision Medicine, GlaxoSmithKline, Collegeville, USA.
Journal of histotechnology
|September 3, 2024
概括
有限的组织样本阻碍了生物标志物的发现. 数字空间分析 (DSP) 能够从单个幻灯片中分析整个转录组和蛋白质,促进药物开发和生物标志物识别.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 药物开发的生物标志物发现受到活检组织有限的可用性挑战.
- 传统的"omics"和单细胞转录组学缺乏空间上下文,限制了组织异质性和细胞相互作用的分析.
- 目前的空间转录组学平台的吞吐量低,转录组覆盖范围有限.
研究的目的:
- 引入数字空间分析 (DSP),作为固体组织中生物标志物分析的进步.
- 以突出DSP从单个组织幻灯片进行可扩展的整个转录组和超高复合蛋白分析的能力.
- 介绍药物发现和开发中的空间研究的最佳实践指南.
主要方法:
- 数字空间分析 (DSP) 用于全转录组和蛋白质分析.
- 在单个幻灯片上分析不同的组织部分和结构.
- 由DSP科学联盟制定最佳实践指南.
主要成果:
- DSP克服了传统方法的局限性,通过在不牺牲空间背景的情况下实现全面分析.
- DSP允许在组织架构内对RNA和蛋白质进行可扩展,高复合的分析.
- 组织分析的进步加深了对疾病生物学和治疗点的理解.
结论:
- DSP显著增强了固体组织中的生物标志物分析,克服了以前的限制.
- 这些进展对于了解疾病机制和识别新型治疗点至关重要.
- 最佳实践指南旨在标准化和改进空间生物学工具在药物发现中的应用.
关键词:
数字空间配置文件的数字空间配置文件在GeoMx DSP中使用.最佳实践的最佳实践是什么生物标志物发现发现空间生物标志物的空间生物标志物空间蛋白质组学 空间蛋白质组学空间转录学 空间转录学组织造型分析 组织造型分析更多相关视频
相关概念视频
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


